MEETING OF THE FEDERAL PARTNERS IN TECHNOLOGY TRANSFER (FPTT) – NATIONAL JUNE 1 ST 2005 EILEEN RAYMOND – INDUSTRIAL AFFAIRS

2 Plant surface – m 2 – 2003 (now) m 2 Personnel – Employees of BRI – CNRC262 – Guest workers163 – Students105 – Company employees393 TOTAL BRI expenses – Financed by BRI budget$ M – Financed by NRC special projects$ M – Financed by revenues generated by BRI$ M

3 The Biotechnology Research Institute is committed to the mission of the National Research Council in serving the needs of Canadians by helping to maintain and enhance the economic and social well- being of the country. The Biotechnology Research Institute promotes, assists and performs leading- edge research and development in biochemical engineering, molecular biology and genomics, closely linked to the needs of the industries in the pharmaceutical and environmental sectors.

4 Macromolecular Structure Protein Chemistry Enzymology Biomolecular NMR The Receptor, Signaling and Proteomics Computational Chemistry Mammalian Cell Genetics Genetics Microbial & Enzymatic Technology Animal Cell Culture Genomics and Gene Therapy Vectors Environment Genetics Environmental Microbiology Environmental Bioengineering Analytical Chemistry Biosensors Applied Ecotoxicology Bioconversion / Sustainable Development Director General Building Engineer Finance & Administration Human Resources Industrial Affairs Director Health Director Bioprocess Director Environment Director

5 – 31 new collaboration agreements – 50 active collaboration agreements – 46 canadian partners (92%) Distribution of active collaboration agreements in COLLABORATIONS

6 IP COMMITTEES Background 2001 Comments 2005 Author – Andy Storer Director Health Sector NRC IPMC Meeting at BRI First IP Committee September 1999

7 IP COMMITTEES Background 2001 Comments 2005 Bottleneck in Technology Transfer (Resources) Need to strenghten technologies for patenting 2005

8 IP COMMITTEES Background 2001 Comments 2005 Paperwork issues at the beginning Implemented to Bioprocess and Environment Sectors (2001) Follow-up of actions difficult for a long time Structure changes needed 2004/2005 model : mature and functional

9 IP COMMITTEES Background 2001 Comments 2005 No change

10 IP COMMITTEES Background 2001 Comments 2005 No change

11 IP COMMITTEES Background 2001 Comments 2005 Number of total presentations has dropped through the years Number of publications maintained More "parcels" of research presented (gaining 6 months earlier) Comparison checks need to be done Publications vs Presentations Issues with principal authors outside

12 IP COMMITTEES Background 2001 Comments 2005 On the spot with the right people, open discussion for screening decision (hold or publish) using simplified criteria: –1º Patentability: new, useful, non obvious (Form 1) –2º Some intuitive market rational –3º Follow-up on research –If more info is needed, postpone decision to next month

13 IP COMMITTEES Background 2001 Comments 2005 Duly completed Form 1 and manuscripts are assessed to ensure sufficient data is provided to support a useful scope of claims for patent applications

14 IP COMMITTEES Background 2001 Comments 2005 Improvement ongoing for timeline of tasks and actions

15 IP COMMITTEES Background 2001 Comments 2005 Paperwork issues Coordination issues Follow-up on actions issues Marketing resources issues For a long time still reactive mode facing deadlines

16 IP COMMITTEES Background 2001 Comments 2005 For few years, number of files increased Number of files decreased to reach a plateau due to better selectivity Better management for older files including dropping cases when appropriate Knowledgeable scientists on IP issues 2005

17 IP COMMITTEES Background 2001 Comments 2005 First IP Committee – September 1999 Prior to 1999, few files Following the growth, a switch from quantity to quality

18 IP COMMITTEES Background 2001 Comments 2005 Cost control was reached in 2004 Less files and better control (IP AUDIT) Culture shift allows the IP integration within daily R&D work A Patent is not something on the side for anyone! Need to link IP Management and Project Management Need resources for technology assessment, marketing and technology transfer 2005

19 IP Committees (2004 / 2005 Model) IP COMMITTEE Operation 1 committee per Scientific Sector Environment, Bioprocess, Health) 1 monthly meeting in 2 parts – Scientific presentation (open to all) – PART 1 Decision on protection and/or publication – IP portfolio management – PART 2 Controlling fees and follow-ups on files, with actions of protection and marketing Composition : – Sector Director (presides meeting) – Director of Industrial Affairs – Group leaders (3 permanents/18 months) – 1 Patent Agent (IPS Ottawa) – 1 IP Coordinator – 2 Business Development Officers (BDOs) Separate work-meetings for prioritary files – Valuation of technology – Strategy and actions to ensure Technology Transfer

20 Business Affairs Opportunity (1 pager)

21 Business Affairs Opportunity (1 pager)